TherapeuticsMD (TXMD) Revenue (2011 - 2026)
TherapeuticsMD (TXMD) posted Revenue of $724000.0 for Q1 2026, down 18.92% on a QoQ basis from $893000.0 in Q4 2025, and up 84.22% year-over-year from $393000.0 in Q1 2025.
TherapeuticsMD (TXMD) Revenue (2011 - 2026) Analysis & Trends
TherapeuticsMD's Revenue history runs 16 years deep, the most recent figure standing at $724000.0 for Q1 2026.
- Quarterly Revenue rose 84.22% year-over-year to $724000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 82.13% YoY) and the FY2025 annual result came in at $3.0 million, up 71.61% from the prior year.
- Revenue was $724000.0 for Q1 2026 at TherapeuticsMD, down from $893000.0 in the prior quarter.
- Across five years, Revenue topped out at $68.6 million in Q4 2022 and bottomed at $53000.0 in Q3 2023.
- A 5-year average of $4.5 million and a median of $469000.0 in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue slumped 99.32% — and 2024, when it soared 932.08%.
- TherapeuticsMD's Revenue stood at $68.6 million in 2022, then slumped by 99.32% to $469000.0 in 2023, then soared by 42.22% to $667000.0 in 2024, then surged by 33.88% to $893000.0 in 2025, then declined by 18.92% to $724000.0 in 2026.
- Business Quant data shows TXMD's Revenue at $724000.0 in Q1 2026, $893000.0 in Q4 2025, and $784000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | TherapeuticsMD | 278,799.99 | -8.14 Mn | - | 724,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724,000.00 |
| Dec 31, 2025 | 893,000.00 |
| Sep 30, 2025 | 784,000.00 |
| Jun 30, 2025 | 952,000.00 |
| Mar 31, 2025 | 393,000.00 |
| Dec 31, 2024 | 667,000.00 |
| Sep 30, 2024 | 547,000.00 |
| Jun 30, 2024 | 234,000.00 |
| Mar 31, 2024 | 313,000.00 |
| Dec 31, 2023 | 469,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Jun 30, 2023 | 437,000.00 |
| Mar 31, 2023 | 416,000.00 |
| Dec 31, 2022 | 68.57 Mn |
| Sep 30, 2022 | 354,000.00 |
| Jun 30, 2022 | 348,000.00 |
| Mar 31, 2022 | 695,000.00 |
| Dec 31, 2021 | 18.68 Mn |
| Sep 30, 2021 | 25.41 Mn |
| Jun 30, 2021 | 23.00 Mn |